.
.
http://lm360.us/Abruzzino-son-of-Delprincipe-from-Nagaokashi?Teodoroso=173 -
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.: bwire: the major problem at knh is structural and system failures
.
![](/s.abcnews.com/images/health/gty-mumps-virus1-mem-170125_16x9t_240.jpg)
![j plus](/www.thejakartapost.com/skin/img/jplus/logo.png)
.